Press releases
- Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
- Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
- Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
More ▼
Key statistics
On Monday, Heron Therapeutics Inc (0J4V:LSE) closed at 2.74, -14.63% below its 52-week high of 3.21, set on Mar 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.74 |
Average volume | 5.55k |
---|---|
Shares outstanding | 150.33m |
Free float | 149.29m |
P/E (TTM) | -- |
Market cap | 392.36m USD |
EPS (TTM) | -0.8695 USD |
Data delayed at least 20 minutes, as of May 06 2024 16:00 BST.
More ▼